A Study of the Safety and Efficacy of Tarceva in Patients With First Relapse of Grade IV Glioma (Glioblastoma Multiforme)
Clinical trial NCT00337883 · COMPLETED
Trial details
- NCT number
- NCT00337883
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-07-01
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.